Formidable Asset Management, LLC Cybin Inc. Transaction History

Formidable Asset Management, LLC

$594 Million
Q1 2024

A detailed history of Formidable Asset Management, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Formidable Asset Management, LLC holds 114,250 shares of CYBN stock, worth $29,705. This represents 0.01% of its overall portfolio holdings.

Number of Shares

114,250

Previous 102,350 11.63%

Holding current value

$29,705

Previous $41,000 12.2%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.3 - $0.46 $3,570 - $5,474	11,900 Added 11.63%	114,250 $46,000
Q4 2023 Feb 07, 2024	BUY	$0.38 - $0.65 $6,080 - $10,400	16,000 Added 18.53%	102,350 $41,000
Q3 2023 Nov 09, 2023	BUY	$0.29 - $0.63 $1,884 - $4,095	6,500 Added 8.14%	86,350 $45,000
Q2 2023 Aug 15, 2023	BUY	$0.23 - $0.39 $2,645 - $4,485	11,500 Added 16.83%	79,850 $30,000
Q1 2023 May 09, 2023	BUY	$0.3 - $0.56 $7,140 - $13,328	23,800 Added 53.42%	68,350 $26,000

Q4 2022 Feb 07, 2023	BUY	$0.26 - $0.47 $1,820 - $3,290	7,000 Added 18.64%	44,550 $13,000
Q3 2022 Nov 14, 2022	SELL	$0.54 - $1.11 $540 - $1,110	-1,000 Reduced 2.59%	37,550 $18,000
Q2 2022 Aug 16, 2022	SELL	$0.41 - $0.88 $594 - $1,276	-1,450 Reduced 3.62%	38,550 $23,000
Q1 2022 May 04, 2022	BUY	$0.74 - $1.22 $11,766 - $19,398	15,900 Added 65.98%	40,000 $33,000
Q4 2021 Feb 07, 2022	BUY	$1.13 - $2.31 $15,763 - $32,224	13,950 Added 137.44%	24,100 $29,000
Q3 2021 Nov 10, 2021	BUY	$1.83 - $3.18 $18,574 - $32,277	10,150 New	10,150 $22,000

Others Institutions Holding CYBN

# of Institutions

108

Shares Held

243M

Call Options Held

Put Options Held

View Full List

About CYBIN INC.

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

More about CYBN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.

Account

Formidable Asset Management, LLC Cybin Inc. Transaction History